NewDays Expands Science-Backed Cognitive Treatment to New York

Innovative Cognitive Treatment Program Brings New Weapons in the Fight Against Cognitive Decline to 3.4+ Million Older New Yorkers

SEATTLE – December 10, 2025 – NewDays, which provides an innovative cognitive treatment program, today announced its expansion to New York, making science-led, cutting-edge care available to the state's 3.4 million residents aged 65 and older. This marks the company's fifth state launch, following successful deployments in Washington, California, Florida, and Texas.

Nearly one in three older adults will experience mild cognitive impairment (MCI) or dementia, affecting more than 1 million New Yorkers. Yet most are told there's nothing they can do beyond "wait and see." NewDays is changing that narrative with treatments and therapies powered by AI and supported by dedicated clinicians every step of the way.

"Too many people facing cognitive decline are told to simply accept it, that there's no real treatment available," said Babak Parviz, CEO and co-founder of NewDays. "The science proves otherwise. Our mission is to bring clinically-validated cognitive treatment to as many people as possible, as quickly as possible. Expanding to New York means more than a million additional people now have access to care that can truly make a difference in their lives."

Science-Led Treatment That Delivers Results

NewDays is built on the groundbreaking I-CONECT study, a multi-site randomized controlled trial that demonstrated significant cognitive improvements through guided conversational engagement. The program's cutting-edge approach helps patients:

• Delay symptom progression

• Regain lost abilities based on individual goals

• Improve memory, processing speed, and verbal fluency

The program combines video visits with licensed neuropsychologists and daily therapeutic conversations powered by AI, making previously inaccessible cognitive rehabilitation available at scale with expert clinical support at every step.

Meeting the Urgent Need for Cognitive Care

The expansion comes at a critical time. New York's aging population is growing rapidly, yet access to cognitive specialists remains limited. Traditional cognitive rehabilitation requires extensive one-on-one time with trained clinicians, a model that simply cannot scale to meet the millions who need care.

NewDays holds the exclusive license to the I-CONECT study protocols, including 900+ guided conversations used in clinical treatment. This unique combination of clinical expertise and advanced AI technology enables the program to deliver evidence-based treatment that was previously available only to research participants.

Getting Started

New Yorkers interested in NewDays can visit newdays.ai to schedule a free consultation and learn more about how cognitive health treatment can help.